BTSG

BrightSpring Health Services reported robust first-quarter 2026 financial results, surpassing analyst expectations, which led to a stock price increase. The company increased its full-year 2026 guidance for both revenue and Adjusted EBITDA. The completion of the sale of its Community Living business to Sevita generated approximately $811 million in net cash proceeds and improved the company's leverage ratio. Concurrently, BrightSpring executed a $60.0 million share repurchase in March 2026. Analysts have maintained a "Buy" consensus rating for the stock, with several firms raising their price targets. The stock reached a new 52-week high of $54.77 on May 8, 2026.